Full title: Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

Details: The main purpose of the study was to investigate whether nilotinib treatment can be safely suspended with no recurrence of CML in selected patients who responded optimally on this treatment

 

Specialty: Hematology

Principal Investigator: Professor Michael O'Dwyer

Study status: Follow up

Identifier: NCT01784068